GlassScriptPhysician profile
Michael Robles Vega
NPI 1740205715
$1,887.89
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $175 · 2020: $464 · 2021: $427 · 2022: $397 · 2023: $281 · 2024: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $425.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $425.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $612.12 | 2019-2024 | Collagenase Santyl |
| Paratek Pharmaceuticals, INC. | $249.41 | 2021-2024 | Nuzyra |
| Stryker Corporation | $231.34 | 2020-2022 | |
| Abbvie INC. | $91.38 | 2023 | Dalvance |
| Bioventus LLC | $90.68 | 2021-2023 | Exogen Ultrasound Bone Healing System |
| Organogenesis INC. | $86.20 | 2021-2022 | |
| Melinta Therapeutics, LLC | $74.97 | 2019-2022 | |
| Tactile Systems Technology INC | $71.95 | 2019-2023 | Entre Plus, Flexitouch Plus |
| Misonix INC | $60.58 | 2019-2020 | |
| Integra Lifesciences Corporation | $44.28 | 2020 | |
| Wright Medical Technology, INC. | $32.85 | 2020 | |
| Kerecis Limited | $26.97 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Reprise Biomedical, INC. | $24.08 | 2024 | Miro3d |
| Medela LLC | $23.27 | 2020 | |
| Medtronic, INC. | $22.94 | 2024 | Intellis Adaptivestim |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $20.84 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Biotissue Holdings INC. | $19.62 | 2021 | |
| Amniox Medical, INC. | $19.55 | 2020 | |
| Kci USA, INC. | $19.50 | 2021 | |
| Merck Sharp & Dohme LLC | $17.21 | 2019 | |
| Arthrosurface Incorporated | $16.78 | 2020 | |
| Arbor Pharmaceuticals, INC. | $16.41 | 2020 | |
| Horizon Therapeutics Plc | $14.96 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Vega listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.